- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3340EUR$3,500USD£2,799GBP
- Report
- October 2024
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- December 2021
Global
From €4629EUR$4,850USD£3,878GBP
The Carbapenemase Test market is a subset of the Infectious Disease Testing market. It is used to detect the presence of carbapenemase enzymes, which are produced by certain bacteria and can cause antibiotic resistance. The test is used to identify the presence of these enzymes in order to determine the best course of treatment for a patient. It is also used to monitor the spread of antibiotic-resistant bacteria in a population.
The Carbapenemase Test market is composed of a variety of companies that provide testing services and products. These include companies such as bioMérieux, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. These companies offer a range of products, including test kits, reagents, and instruments. Show Less Read more